Tagged with Clinical Trials,

Pharma The President of Fefis, and the recently elected President of Medicen Paris Region, a Paris-based business cluster, talks about the need to build the future of the French health economy, not on past and current assets but to develop new ones; reveals how there is now a growing awareness of the…

Pharma The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical trials; how Triclinium has grown during a challenging decade, emerging as the largest independent home-bred CRO, winning significant preferred provider…

Pharma Centre International de Développement Pharmaceutique (CIDP) has pioneered cosmetic and pharmaceutical Research & Development in Mauritius, and is Mauritius’ flagship success story in the sector. Founded over 10 years ago, CIDP is an international CRO (Contract Research Organisation). As an entrepreneur and a pioneer, which opportunities did you see in Mauritius that…

Research Arnaud Lagesse, CEO of GML, the largest company in Mauritius and the third largest company in the Indian Ocean, discusses his company’s successful diversification into the life sciences sector, with the creation of GML Life. The history of GML has always been linked to the development of the Mauritian economy.…

manufacturing The chancellor of the Medical Sciences Campus of the University of Puerto Rico discusses the medical R&D projects the university is currently involved in, the fields in which the island has the most potential, and how the institution is tailoring its academic offer to suit the local needs of the…

clinical trials ACLIRES’ senior vice president explains the organization’s ambitions to promote Thailand as a unique place for early phase studies, the company’s partnership with Mahidol University and Siriraj Hospital and its dedication to the development of medicine for Thailand, the region and the world.   What brought you to work at ACLIRES?…

CRO Omega CRO has evolved from its beginnings as a CRO contracted by local and multinational pharmaceutical companies into an organization leading clinical, epidemiological and observational studies of public interest across Turkey. CEO Berk Özdemir discusses the highlights of these studies, including a giant EU 7th Framework project EU-GEI study on…

Parexel Claudio Soto, general manager of PAREXEL Mexico, discusses how the clinical research process required to receive approval for a new clinical protocol in Mexico is fairly straightforward compared to other countries in Latin America. She also addresses the government´s increasing awareness of the importance of their role in helping to…

CRO The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of how the already booming clinical research is expected to thrive, and how there will remain plenty of work for all.…

CRO The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of how the already booming clinical research is expected to thrive, and how there will remain plenty of work for all.…

CRO The general manager of one of the leading CROs in Romania explains how the country in gathering pace as a top tier clinical trials destination country within the region and how the priority is now about on-time project delivery. Could you please start by introducing PSI and its engagement with…

Actelion Turkey has been a high priority market for Actelion since the company’s relatively recent beginnings, and the general manager of the local affiliate discusses his affiliate efforts to improve awareness around this rare disease through open communication with health authorities, and the need for formal recognition of orphan drugs by…